Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Japan chastises Nobel laureate-led research team after data fabrication

Published 01/23/2018, 04:47 AM
Updated 01/23/2018, 04:50 AM
© Reuters. Nobel medicine laureate Yamanaka of Japan speaks during a news conference at the Karolinska Institutet in Stockholm

TOKYO (Reuters) - Japan chastised a Kyoto University stem cell research team led by Nobel laureate Shinya Yamanaka on Tuesday after a team member fabricated data in his paper, saying it shook people's trust in scientific research.

Education Minister Yoshimasa Hayashi's comments came a day after Kyoto University announced that a researcher at Yamanaka's research unit had falsified data in his paper published last year in the U.S. scientific journal Stem Cell Reports.

The misconduct "is something that shakes the people's trust in research activities and is extremely regrettable," Hayashi told reporters. "We would like to instruct Kyoto University to do its utmost to prevent a recurrence."

Yamanaka in 2012 shared a Nobel Prize for medicine with British scientist John Gurdon for the discovery that adult cells can be transformed back into embryo-like stem cells that may one day regrow tissue in damaged brains, hearts or other organs.

"I regret and reflect that the research paper misconduct like this happened," Yamanaka told reporters. "I offer my heartfelt apology."

Kyoto University has already asked for retraction of the paper.

In a recent case of discredited research findings, Japanese scientist Haruko Obokata in 2014 detailed simple ways to reprogram mature animal cells back to an embryonic-like state in research papers published in the scientific journal Nature.

But questions soon arose about her research as other scientists could not replicate the claims and a research institute she was working for said she had plagiarized and fabricated parts of the papers.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.